Nasopharyngeal carcinoma (NPC) is mainly caused by EBV infection, and clinical trials have shown that anti-PD-1 therapy can increase the one-year survival rate in NPC patients [83]. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.